Company Filing History:
Years Active: 2012
Title: Rita Barresi: Innovator in Muscle Degeneration Treatment
Introduction
Rita Barresi is a prominent inventor based in Iowa City, IA (US). She has made significant contributions to the field of medical research, particularly in the treatment of muscle degeneration. Her innovative approach focuses on enhancing the functional glycosylation of alpha-dystroglycan, which plays a crucial role in muscle health.
Latest Patents
Rita Barresi holds a patent for a method aimed at preventing and treating muscle degeneration. The patent, titled "Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration," discloses a method where a subject identified with muscle degeneration is treated with a composition that effectively increases the functional glycosylation of alpha-dystroglycan in the affected tissue. This method aims to restore the binding of alpha-dystroglycan to its ligands in the affected tissue to levels comparable to those in healthy tissue. One effective means of achieving this involves increasing glycosyltransferase activity, such as LARGE or LARGE2 activity, in the muscle of the subject. Additionally, therapeutic glycosylated peptide compositions are provided in her patent.
Career Highlights
Rita Barresi is affiliated with the University of Iowa Research Foundation, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to significantly impact the lives of individuals suffering from muscle degeneration.
Collaborations
Rita collaborates with Kevin P Campbell, a fellow researcher, to advance their understanding and treatment of muscle-related conditions. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Rita Barresi's contributions to the field of muscle degeneration treatment highlight her innovative spirit and dedication to improving patient outcomes. Her patent represents a significant step forward in medical research, showcasing the potential for new therapies in combating muscle degeneration.